Given the strong induction of Trem2 expression during MASH, circulating levels of soluble Trem2 (sTrem2) in MASH were demonstrated to correlate with disease severity in mice and humans [37]. This evidence concerns the gene TREM2 and metabolic dysfunction-associated steatohepatitis.